Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001213900-24-094654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-05 | 2024-11-01+ | HRMY | VALOR EQUITY PARTNERS IV-B L.P. | 10% | S - Sale | $30.30 | -4.60M | 6.62M | -41% | -$139.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | S | D | 4,000,000 | $30.30 | 7,218,033 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-05 | S | D | 600,000 | $30.30 | 6,618,033 | D | — | — |